National Health Insurance Scheme (NHIS) and Roche Products Nigeria Limited have reached plans to partner on an innovative cost-sharing mechanism to ensure the affordability of drugs for cancer patients at treatment centres.
General Manager, Roche Products Ltd., Nigeria, Dr. Ladi Hammeed, described the partnership as a significant and commendable milestone for cancer care in Nigeria, expressing optimism that patients will no longer have to deal with the consequences of diagnosis.
He noted that funding for early treatment, comprehensive care – inclusive of surgery, radiotherapy, chemotherapy and targeted therapy – improve treatment outcomes and, ultimately, survival of patients.
Hammeed said the partnership enables both healthcare institutions to engage in capability building initiatives that are designed to support the health insurance ecosystem.
In his remarks, Executive Secretary and Chief Executive Officer of NHIS, Prof. Mohammed Sambo, said the Scheme will bring affordable and quality healthcare to all Nigerians, even as he stressed that the implementation of its ten-year strategic plan was on course.
Sambo, who was represented by General Manager, Legal Services, Blessing Nienge, explained that the health insurance regulator and Swiss drug giant will work assiduously to attain Universal Health Coverage (UHC) in Nigeria.
The partnership will be piloted in designated centres across the six geopolitical zones of the country.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?